Peregrine Ventures’ Post

Sabah Baxamoosa discusses with Glen Gardner President of Gardner Innovation Search Partners the evolving role of medical schools in the tech transfer landscape. From dedicated tech transfer offices to emerging chief business officers, medical schools are finding new ways to engage Big Pharma for impactful research and strategic partnerships. Tune in to the full episode to uncover how leading universities are reshaping tech transfer strategies and maximizing licensing revenue through innovative approaches. Watch here 👉 https://bit.ly/3V0A763 #OneValley #BVIE #Innovation #Entrepreneurship #StartupEnablement #GardnerISP #TechTransfer

🌐 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡: 𝐓𝐑𝐔𝐌𝐏𝐅 𝐕𝐞𝐧𝐭𝐮𝐫𝐞'𝐬 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 Resistell🌐   We’re proud to be invested in our portfolio company Resistell since 2019 (https://resistell.com/), a leader in the development of rapid 𝐚𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜 𝐬𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 (𝐀𝐒𝐓) 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬. This partnership underscores our commitment to pioneering solutions that address critical global health challenges, specifically antimicrobial resistance (AMR).   Resistell’s innovative approach leverages patented Nanomotion𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐭𝐨 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐀𝐒𝐓 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐢𝐧 𝐮𝐧𝐝𝐞𝐫 𝟖 𝐡𝐨𝐮𝐫𝐬, 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭𝐥𝐲 𝐟𝐚𝐬𝐭𝐞𝐫 𝐭𝐡𝐚𝐧 𝐭𝐫𝐚𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐦𝐞𝐭𝐡𝐨𝐝𝐬. This capability is crucial for effective treatment decisions and combating the rise of superbugs, which are responsible for millions of deaths annually.   Our investment in Resistell is a strategic alignment with our goal to 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐠𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 that have a substantial impact on public health. As Resistell progresses towards setting a new gold standard in AST, TRUMPF is excited to be at the forefront of this transformative healthcare initiative.   We invite the healthcare community and our industry partners to join us in supporting Resistell's mission to revolutionize medical diagnostics. Learn more about how our collaboration is shaping the future of healthcare.   (The team behind the technology: Danuta Cichocka, Grzegorz Gonciarz, Martin Birk, Dieter Kraft) #HealthTech #MedicalInnovation #AntimicrobialResistance #TRUMPF #CorporateVentureCaptial

If you are attending the LSX - partnering for Life Science eXecutives Medtech Summit in Boston this week, you don't want to miss out on the fantastic panel of SMEs that I have the privilege of moderating as we discuss Cash, Crew, & Commercialization: A Startup's Journey to Success. Join Sergio Levi, Esmeralda Megally, Romeo Catracchia, & Carla Reimold as we discuss strategies around: - A-Z Funding - Building Your Team & Hiring for Culture - Going through the Stages of Commercialization -Finding Strategic Partners for Scale See you in Boston! #startupsuccess #innovation #medtech #lifesciences #winningthejourney #riskmanagement #qualitymatters #leadershipmatters

The #NotifiedBody plays a central role in the process of becoming a medical device manufacturer. We spoke to Dietmar Schaffarczyk, auditor at QS Schaffhausen AG, to find out more about what the NB expects from young #MedTech startups.   Our key takeaways: ◾ NBs must maintain their independence in their assessments, which is why they must not offer direct advice. ◾ While each company must be compliant, NBs take into account the current status of a company. ◾ Long-term success can only be guaranteed by building internal expertise in addition to external support. ◾ When you first contact an NB for a QMS audit, for example, 65% of the documentation should be ready. Read the full interview here 👉 https://lnkd.in/gTvz9a5e

We are thrilled to join the Intellectual Property Management Clinic - FemTech program, a groundbreaking initiative led by World Intellectual Property Organization – WIPO, the Canadian Intellectual Property Office (Innovation, Science and Economic Development Canada), and the Israel Patent Office.    This program supports 20 selected SMEs and startups from Canada and Israel, focusing on innovative solutions to improve women's health and well-being.   Women's health impacts over 51% of the global population, and the FemTech market is projected to exceed $4.8 trillion by 2025! Investing in FemTech innovation is crucial for advancing research and enhancing women's lives. Intellectual property (IP) plays a pivotal role in driving this innovation.   sanoLiving is proud to be among stellar companies: Shela, New Attitude Prosthetic Designs Inc, FEMSelect, Cosm Medical, GynTools Dio Tree, Revyn Medical Technologies Inc, Linok, WunderWear Inc., EndoSpot, Héra care solutions., Forfve, Neuraura, Aquafit Intimate, Zetect Technologies, Daily Goods Design Labs and Maxovary. Learn more at: https://lnkd.in/ggyA9FuC #FemTech #Innovation #WomensHealth #IPManagement #Startups #CanadianInnovation #SMEs #GlobalHealth #WIPO #CIPO 🌍 👩🔬

Having a concise 1 minute, (or less) elevator pitch is crucial for any startup seeking capital. If you’re a Medtech company attending Medtech Leaders at LSX - partnering for Life Science eXecutives World Congress in London next week, pay attention and be prepared! I love this template, shared by Rubén D. is 🔥 to nail it every time: 1. [Company] is a [offering] that [value prop] 2. We're targeting the [market] market, which hit [market size] last year 3. We're up against [competitor1] and [competitor2], but we [key differentiator] 4. We've [current state] 5. We're looking for [the ask] to help us [goal] Concise, compelling, and crushes all the key points. Credit: Chris Tottman

Hope you listen (or forward) to the end of the video because I share something I think is especially important to say right now. We’re just over 2 weeks away from thousands of innovators, investors, strategics, and more joining together at the Epicenter of Medtech in Dana Point, CA. A couple updates... 1. Partnering is cranking and investors are getting assertive (great to see) We just cracked 1,000 partnering meetings and growing fast. Expecting over 5,000 meetings this year. Let's get some deals done. If you're an attending investor or strategic and want more info on the 325 presenters, send Andrew Stadnick an email (his details are in the comments) 2. LSI Alumni Virtual Incision & Arga Medtech with big wins this week Congrats to Virtual Incision on their FDA Authorization for MIRA Surgical System this week. Tip of the hat to their investors (also LSI Alumni) Endeavour Vision and cultivate(MD). Congrats to Arga Medtech on closing a €54 Million round. And another hat tip to their investors (also LSI Alumni) Gilde and Early Bird. 3. Panel celebrating Startup Nation Excited to spotlight Israel’s thriving innovation and investment ecosystem while highlighting their crucial role in Medtech and Healthtech globally during a timely session, “Israel: Past, Present & Future of Medtech Innovation in StartUp Nation.” See you in Dana Point.

🚨Medical Device Startups: Navigate Challenges to Ensure Your Success!🚨 At MEDevice Silicon Valley, F. David Rothkopf, founder of Medicept, will discuss why many medical device startups fail. It’s not just about having a great idea—it’s about navigating regulatory, clinical, and reimbursement challenges that can make or break your success. Our platform can support your innovation every step of the way. Attend F. David Rothkopf's session, then stop by Enlil’s booth #859 to learn how to overcome common startup challenges to set your innovation up for success! 📈 🔗 Read Susan Shepard’s MD + DI article for more details.https://zurl.co/aQUZ #MedTech #StartupSuccess #Regulatory #Clinical #Innovation #MEDevice #Enlil

Medtech Snapshot Look Back: Glen Rabito COO of Nidus Biomedical shares with us 5 key areas startups need to be mindful of in order to keep the product development cycle moving forward. #2 covering clinical and technical risks - spot on! https://lnkd.in/gg7JbEZu #medtech #snapshot #medicaldevice #riskmanagement #startup #productdevelopment

🎉 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐍𝐞𝐰𝐬! 🎉   We’re proud to share that EarlySight has been ranked among the 𝐓𝐨𝐩 100 𝐒𝐰𝐢𝐬𝐬 𝐒𝐭𝐚𝐫𝐭-𝐮𝐩𝐬 𝐨𝐟 2024  #Top100SSU , placing 6𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐜𝐚𝐭𝐞𝐠𝐨𝐫𝐲 and 48𝐭𝐡 𝐨𝐯𝐞𝐫𝐚𝐥𝐥! 🎉     🔍 𝐖𝐡𝐲 𝐄𝐚𝐫𝐥𝐲𝐒𝐢𝐠𝐡𝐭 𝐜𝐨𝐧𝐯𝐢𝐧𝐜𝐞𝐝 𝐭𝐡𝐞 𝐣𝐮𝐫𝐲 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫?  Our mission is clear: 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐭𝐡𝐞 𝐞𝐚𝐫𝐥𝐲 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐞𝐲𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 through unparalleled imaging technology. In April 2023, we launched production of our flagship product, 𝐂𝐞𝐥𝐥𝐮𝐥𝐚𝐫𝐢𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲, which sold out in its first run! 🚀 This advanced retinal camera offers 𝐭𝐞𝐧𝐟𝐨𝐥𝐝 𝐢𝐦𝐚𝐠𝐞 𝐫𝐞𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 compared to current standards, and we are the only company with patented 𝐀𝐝𝐚𝐩𝐭𝐢𝐯𝐞 𝐎𝐩𝐭𝐢𝐜𝐬 𝐓𝐫𝐚𝐧𝐬𝐬𝐜𝐥𝐞𝐫𝐚𝐥 𝐅𝐥𝐨𝐨𝐝 𝐈𝐥𝐥𝐮𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧 (𝐀𝐎-𝐓𝐅𝐈) technology, allowing unprecedented observation of RPE cells.   💡 𝐊𝐞𝐲 𝐀𝐜𝐡𝐢𝐞𝐯𝐞𝐦𝐞𝐧𝐭𝐬:   👉 A dedicated 𝐭𝐞𝐚𝐦 that delivers, overcoming the challenges of a start-up.  👉 Over 600 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 have been examined using our technology, yielding invaluable insights into retinal pathologies.   👉 Exciting new collaborations with pharma companies who see cellular-resolution imaging as essential for developing 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬.   Thank you to our amazing team, partners and customers for believing in our vision and helping us reach new heights. We’re excited for what’s next!     The 𝐓𝐨𝐩 100 𝐒𝐰𝐢𝐬𝐬 𝐒𝐭𝐚𝐫𝐭-𝐮𝐩 𝐀𝐰𝐚𝐫𝐝 is a benchmark event, highlighting Switzerland’s most promising and innovative ventures. Over the past decade, 553 deep-tech start-ups have featured in the ranking, creating nearly 19,000 jobs and raising over CHF 13.6 billion. We’re honoured to be part of this incredible community, recognized by a jury of investors, successful entrepreneurs, and key ecosystem stakeholders.      #Innovation  #StartupJourney #Top100SwissStartups #MedTech #Innovation #EyeHealth #RetinalImaging #EarlySight #CellularResolution